Inhalt - Detail

Asahi Kasei Pharma seeks new drug seeds

  • 10.09.2015


To tackle the challenges of demographic change, Asahi Kasei Pharma Corporation aims to bring new, innovative treatments to patients with autoimmune diseases, including rheumatoid arthritis, by combining its drug development capabilities with drug seeds of development partners.

Asahi Kasei Pharma is looking for drug seeds that are in an early stage of development and have already proven their efficacy in in vivo tests.

Responses to this request should include an executive summary (in English, about 3 pages), outlining the drug seeds and the desired collaboration with Asahi Kasei Pharma. The response can be submitted online.

Deadline: 10.09.2015

More information about Asahi Kasei Pharma
Request flyer